We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Department of Anesthesiology

You are here

Isoflurane Modulates Hippocampal Cornu Ammonis Pyramidal Neuron Excitability by Inhibition of Both Transient and Persistent Sodium Currents in Mice.

TitleIsoflurane Modulates Hippocampal Cornu Ammonis Pyramidal Neuron Excitability by Inhibition of Both Transient and Persistent Sodium Currents in Mice.
Publication TypeJournal Article
Year of Publication2019
AuthorsZhao W, Zhang M, Liu J, Liang P, Wang R, Hemmings HC, Zhou C
Date Published2019 Jul

WHAT WE ALREADY KNOW ABOUT THIS TOPIC: Neurotransmitter release from presynaptic nerve terminals is hindered by volatile anesthetics through inhibition of voltage-gated sodium channelsDepression of neuronal activity by volatile anesthetics through direct inhibition of sodium currents in excitatory neurons has not been previously reported WHAT THIS ARTICLE TELLS US THAT IS NEW: Electrophysiologic studies show that isoflurane, at clinically relevant concentrations, inhibits both transient and persistent sodium currents on mouse cornu ammonis hippocampal neurons ex vivoThe isoflurane-induced inhibition of sodium channels on excitatory neurons may contribute to the reduction of neuronal excitability and synaptic transmission BACKGROUND:: Volatile anesthetics inhibit presynaptic voltage-gated sodium channels to reduce neurotransmitter release, but their effects on excitatory neuron excitability by sodium current inhibition are unclear. The authors hypothesized that inhibition of transient and persistent neuronal sodium currents by the volatile anesthetic isoflurane contributes to reduced hippocampal pyramidal neuron excitability.

METHODS: Whole-cell patch-clamp recordings of sodium currents of hippocampal cornu ammonis pyramidal neurons were performed in acute mouse brain slices. The actions of isoflurane on both transient and persistent sodium currents were analyzed at clinically relevant concentrations of isoflurane.

RESULTS: The median inhibitory concentration of isoflurane for inhibition of transient sodium currents was 1.0 ± 0.3 mM (~3.7 minimum alveolar concentration [MAC]) from a physiologic holding potential of -70 mV. Currents from a hyperpolarized holding potential of -120 mV were minimally inhibited (median inhibitory concentration = 3.6 ± 0.7 mM, ~13.3 MAC). Isoflurane (0.55 mM; ~2 MAC) shifted the voltage-dependence of steady-state inactivation by -6.5 ± 1.0 mV (n = 11, P < 0.0001), but did not affect the voltage-dependence of activation. Isoflurane increased the time constant for sodium channel recovery from 7.5 ± 0.6 to 12.7 ± 1.3 ms (n = 13, P < 0.001). Isoflurane also reduced persistent sodium current density (median inhibitory concentration = 0.4 ± 0.1 mM, ~1.5 MAC) and resurgent currents. Isoflurane (0.55 mM; ~2 MAC) reduced action potential amplitude, and hyperpolarized resting membrane potential from -54.6 ± 2.3 to -58.7 ± 2.1 mV (n = 16, P = 0.001).

CONCLUSIONS: Isoflurane at clinically relevant concentrations inhibits both transient and persistent sodium currents in hippocampal cornu ammonis pyramidal neurons. These mechanisms may contribute to reductions in both hippocampal neuron excitability and synaptic neurotransmission.

Alternate JournalAnesthesiology
PubMed ID31166240
PubMed Central IDPMC6586485
Grant ListR01 GM058055 / GM / NIGMS NIH HHS / United States